Buys
Open market- Shares
- +5,000
- Avg price
- $5.72
- Total value
- +$28,600
Ron Bentsur - Chairman & CEO, Director, 10%+ Owner at Nuvectis Pharma, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chairman & CEO, Director, 10%+ Owner
- Issuer Symbol
- NVCT on Nasdaq
- All Insider Reports
- All Insider Reports
Ron Bentsur - trading volume in the past year for Nuvectis Pharma, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +5,000
- Share %
- 100%
- Total value
- +$28,600
Holdings reported by Ron Bentsur for Nuvectis Pharma, Inc.
Form 4 holding
Chairman & CEO, Director, 10%+ Owner
Nuvectis Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 3,675,924
- Estimated value
- $27,752,858
- Report date
- 06 Jan 2026
- Price
- $7.55
- Ownership
- Direct
Transactions reported by Ron Bentsur for Nuvectis Pharma, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.